Deutsche Bundesstiftung Umwelt (DBU): Steinmeier: Let us change course for climate protection and biodiversity
Federal President presents German Environmental Prize
Osnabrück/Darmstadt. With an appeal to our sense of solidarity as a global community, today (Sunday), at the darmstadtium conference centre in Darmstadt, Germany’s Federal President Frank-Walter Steinmeier called for a change of course to conserve biodiversity and stop global warming. At the awards ceremony for the German Environmental Prize, which is awarded by the German Federal Environmental Foundation (DBU), the German President stated that “change can only arise from solidarity”. And: “The ecological transformation will improve our quality of life.” The prize comes with a remuneration of EUR 500,000 and was split equally between ecologist Prof. Dr. Katrin Böhning-Gaese and peatlands researcher Prof. Dr. Dr. h.c. Hans Joosten.
Further information about the German Environmental Prize 2021 to be found at https://www.dbu.de/umweltpreis (German only)
Om news aktuell GmbH
As wholly owned subsidiary of dpa, news aktuell provides business and organizations with effective access to media and consumers. Via the smart tools ots and zimpel, PR content accesses all media formats, including classical print, high click-rate online portals and social networks. In addition, news aktuell publishes all its customers’ PR content on www.presseportal.de, one of the PR portals with the greatest reach in Germany. By this means, all the relevant multipliers are reached globally, from editors, via digital influencers right up to specialist bloggers and interested consumers. news aktuell has been on the market since 1989. The company, with a staff complement of more than 135, has its headquarters in Hamburg. Other offices are in Berlin, Dusseldorf, Frankfurt und Munich.
Følg pressemeldinger fra news aktuell GmbH
Registrer deg med din epostadresse under for å få de nyeste sakene fra news aktuell GmbH på epost fortløpende. Du kan melde deg av når som helst.
Siste pressemeldinger fra news aktuell GmbH
Fleetpool GmbH: Perfect Match: ALD acquires Fleetpool Group:13.10.2021 14:06:52 CEST | Press release
Fleetpool, the German pioneer and market leader in car subscriptions, and leading international mobility provider ALD are joining forces. The two companies have agreed the 100-percent acquisition of the Fleetpool Group by ALD, including its fleet of more than 10,000 vehicles.
Deutsche Hospitality: Deutsche Hospitality and the Porsche Design Group launch a unique hotel concept and plan at least 15 hotels in metropolises right across the world12.10.2021 13:00:00 CEST | Press release
Zeitgeist, Design and Service Excellence.
Deutsche Bundesstiftung Umwelt (DBU): “The award recipients give us hope”11.10.2021 09:41:00 CEST | Pressemelding
Ecologist and peatland researcher receive German Environmental Prize
MARC O'POLO: IT’S ON US. Film premiere in Paris. Marc O’Polo launches new campaign7.10.2021 11:34:46 CEST | Press release
PARIS 7. OCTOBER 2021 Marc O’Polo celebrated several premieres at its campaign launch in Paris yesterday. For the first time in its history, a film and the topic of sustainability were the center of the Scandinavian premium brand’s campaign. In addition, Marc O’Polo made its debut at Paris Fashion Week and left a lasting impression
Elatech GmbH: Elatec Receives Patent for USB Rotary Connector. 360° Mounting: Reader with a Special Twist5.10.2021 11:00:00 CEST | Press release
Elatec's TWN4 USB Front Reader makes it easy to retrofit authentication solutions with a plug & play solution. Elatec has now been granted a patent in Europe and the USA for the reader's USB rotary connector. This enables a unique 360° mounting of the reader. With this extraordinary solution, the company once again demonstrates its innovation and customer orientation.
Grünenthal Group: First participants enrolled in Clinical Trial with Nociceptin/Orphanin peptide receptor (NOP) agonist29.9.2021 11:25:16 CEST | Press release
Aachen, Germany, 29 September 2021 – Today, Grünenthal announced that the first participants have been enrolled in a randomised, placebo- and active-controlled clinical trial for its peripherally restricted Nociceptin/Orphanin FQ peptide receptor (NOP) agonist. The compound is being developed to provide a non-opioid therapy option that offers a strong analgesic effect without the side effects commonly associated with opioids. The Experimental Medicine Trial will evaluate the extent and duration of the pharmacological effect of the oral NOP agonist in an experimental pain model. The results of the trial are expected to be available in early 2022.
I vårt presserom finner du alle våre siste pressemeldinger, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom